Skip to content

Screener Atlas Counties Economy Valuation Saved

For research and education only. Not financial advice. Nothing on TickerFacts recommends buying, selling or holding any investment. Read the limitations

Outlook Therapeutics, Inc. (OTLK) › Cost of Revenue

Outlook Therapeutics, Inc. (OTLK) — Cost of Revenue

Annual figures by period end, from SEC filings.

Period ended	Cost of Revenue	Change YoY	Source filing
2025-09-30	$1.36M	—	2025-12-19From 2024-10-01

Other metrics: Revenue Gross Profit Operating Income Net Income EPS (Diluted)Total Assets Total Liabilities Shareholders' Equity Cash & Equivalents Operating Cash Flow Capital Expenditures Shares Outstanding Dividends Per Share Weighted Average Diluted Shares EPS (Basic)

A clearer view of the business behind the ticker.

API & developers Sources & coverage Source: SEC EDGARNot financial or investment advice.